Tiberias Technology, one of the subsidiaries of Arbele, is dedicated to pioneering advancements in the field of in vitro diagnostics (IVD) specifically tailored for the prevention, detection, and management of GI cancers.

Our comprehensive array of cutting-edge solutions encompasses blood and tissue diagnostics, alongside efficient point-of-care tests. These innovations collectively cover every crucial juncture of the patient’s journey – from the initial phases of early cancer detection through to precise diagnostic procedures, personalized treatment strategizing, vigilant monitoring, and even post-treatment surveillance.

Tiberias Technology endeavors to enhance the landscape of GI cancer care, ultimately contributing to improved patient outcomes and a higher standard of healthcare.